Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front Med    2012, Vol. 6 Issue (1) : 94-99    https://doi.org/10.1007/s11684-012-0181-y
RESEARCH ARTICLE
Scientific publications on systematic review and meta-analysis from Chinese authors: a 10-year survey of the English literature
Zhiping Yang(), Qiong Wu, Kaichun Wu, Daiming Fan
Evidence-Based Medicine Group, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an 710032, China
 Download: PDF(221 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

Systematic reviews and meta-analyses are playing an increasingly important role in clinical research and practice. This study aimed to measure the scientific production of systematic review and meta-analysis from the three major regions of China: the Mainland (ML), Hong Kong (HK), and Taiwan (TW). English articles on systematic review and meta-analysis from ML, HK, and TW from 2001 to 2010 were retrieved from the PubMed database. The total number of articles, impact factors (IF), and articles published in high-impact journals were conducted for quantity and quality comparisons among the three regions. There were 1 587 published articles from ML (1 292), HK (203), and TW (92) during the past ten years. The annual total numbers of articles in the three regions increased significantly from 2001 to 2010 (from 13 to 677). The number of articles from ML has exceeded that from TW since 2001, and surpassed that from HK in 2003. The accumulated IF of articles from ML (3 488.24) was higher than those from HK (493.16) and TW (216.39). HK had the highest average IF of 3.31, followed by ML of 2.90 and TW of 2.85. Researchers from HK published a larger proportion of papers in high-impact journals than those from ML and TW. The Cochrane Database of Systematic Reviews was the most popular journal in China. Chinese authors have been very active to enhance the systematic review and meta-analysis research over the past ten years, especially in ML. The gap between ML and the other two regions has been narrowed. But there is still considerable room for Chinese authors to improve their studies on systematic review and meta-analysis.

Keywords systematic review      meta-analysis      China      Chinese      impact factor     
Corresponding Author(s): Yang Zhiping,Email:zpyang@fmmu.edu.cn   
Issue Date: 05 March 2012
 Cite this article:   
Zhiping Yang,Qiong Wu,Kaichun Wu, et al. Scientific publications on systematic review and meta-analysis from Chinese authors: a 10-year survey of the English literature[J]. Front Med, 2012, 6(1): 94-99.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-012-0181-y
https://academic.hep.com.cn/fmd/EN/Y2012/V6/I1/94
Fig.1  The numbers of articles from China, USA, England of UK, Germany, France, and Japan from 2001 to 2010.
Fig.2  The numbers of articles from the Mainland, Hong Kong, and Taiwan of China from 2001 to 2010.
Fig.3  Productivity of the institution where research had been carried out in the three regions of China.
YearAccumulated IFAverage IF
MLHKTWMLHKTW
20011.9910.760.000.662.150.00
20024.0023.876.860.802.652.29
200325.128.542.762.792.140.92
200415.9717.7713.381.332.542.68
200542.8932.2715.023.063.233.75
2006131.8549.444.672.593.301.56
2007261.7476.1122.083.313.624.42
2008407.5142.1634.242.662.812.14
2009835.17112.7529.802.904.512.98
20101 762.01119.5187.573.003.143.24
Total3 488.24493.16216.392.903.312.85
Tab.1  The accumulated and average impact factors (IF) of articles from the Mainland (ML), Hong Kong (HK), and Taiwan (TW) of China
Fig.4  The distribution of articles from the three Chinese regions during the past ten years in relation to the impact factor.
Fig.5  The distributing proportions of articles from the three Chinese regions during the past ten years in the four impact factor intervals.
RankML (n = 1 292)nHK (n = 203)nTW (n = 92)n
1The Cochrane Database of Systematic Reviews108Hong Kong Medical Journal29Journal of Clinical Nursing8
2Chinese Medical Journal (English Version)77The Cochrane Database of Systematic Reviews20Journal of Advanced Nursing5
3Breast Cancer Research and Treatment62Anesthesia and Analgesia6Kaohsiung Journal of Medical Sciences5
Total247 (19.1%)55 (27.1%)18 (19.6%)
Tab.2  The three most popular English journals for authors from the Mainland (ML), Hong Kong (HK), and Taiwan (TW) of China
RankMLHKTW
JournalIFJournalIFJournalIF
1Annals of Internal Medicine16.729The Journal of American Medical Association28.899The Lancet Neurology12.167
2The Lancet Infectious Diseases16.144Gut10.015Archives of Internal Medicine10.639
3Journal of the National Cancer Institute14.069British Medical Journal9.723Journal of Hepatology9.334
Tab.3  The top three English journals of high impact factors (IF) for authors from the Mainland (ML), Hong Kong (HK), and Taiwan (TW) of China
1 Liberati A, Altman DG, Tetzlaff J, Mulrow C, G?tzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009; 151(4): W65-94
pmid:19622512
2 Cook DJ, Sackett DL, Spitzer WO. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol 1995; 48(1): 167-171
doi: 10.1016/0895-4356(94)00172-M pmid:7853043
3 Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. Epidemiology and reporting characteristics of systematic reviews. PLoS Med 2007; 4(3): e78
doi: 10.1371/journal.pmed.0040078 pmid:17388659
4 Shojania KG, Bero LA. Taking advantage of the explosion of systematic reviews: an efficient MEDLINE search strategy. Eff Clin Pract 2001; 4(4): 157-162
pmid:11525102
5 Top 20 countries in all fields, 2000-August31, 2010. http://sciencewatch.com/dr/cou/2010/10decAll(Access on April 15, 2011)
6 Robinson KA, Goodman SN. A systematic examination of the citation of prior research in reports of randomized, controlled trials. Ann Intern Med 2011; 154(1): 50-55
pmid:21200038
7 Ragghianti CP, Martínez R, Martins J, Gallo JE. Comparative study of scientific publications in Ophthalmology and Visual Sciences in Argentina, Brazil, Chile, Paraguay and Uruguay (1995-2004). Arq Bras Oftalmol 2006; 69(5): 719-723
doi: 10.1590/S0004-27492006000500019 pmid:17187142
8 Wang J. Evidence-based medicine in China. Lancet 2010; 375(9714): 532-533
doi: 10.1016/S0140-6736(09)62131-0 pmid:20159275
9 Carter MJ. Evidence-based medicine: an overview of key concepts. Ostomy Wound Manage 2010; 56(4): 68-85
pmid:20424294
10 Andersen J, Belmont J, Cho CT. Journal impact factor in the era of expanding literature. J Microbiol Immunol Infect 2006; 39(6): 436-443
pmid:17164944
11 Oh HC, Lim JF. Is the journal impact factor a valid indicator of scientific value? Singapore Med J 2009; 50(8): 749-751
pmid:19710968
12 About The Cochrane Library. http://www.thecochranelibrary.com/view/0/AboutTheCochraneLibrary.html#CDSR (Access on April16, 2011)
13 Chinese Cochrane Centre (in Chinese).http://www.hxyx.com/cochrane_new (Access on April16, 2011)
14 Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB; the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283(15): 2008-2012
doi: 10.1001/jama.283.15.2008 pmid:10789670
[1] Xueling Suo, Du Lei, Wenbin Li, Lei Li, Jing Dai, Song Wang, Nannan Li, Lan Cheng, Rong Peng, Graham J Kemp, Qiyong Gong. Altered white matter microarchitecture in Parkinson’s disease: a voxel-based meta-analysis of diffusion tensor imaging studies[J]. Front. Med., 2021, 15(1): 125-138.
[2] Zixin Shu, Yana Zhou, Kai Chang, Jifen Liu, Xiaojun Min, Qing Zhang, Jing Sun, Yajuan Xiong, Qunsheng Zou, Qiguang Zheng, Jinghui Ji, Josiah Poon, Baoyan Liu, Xuezhong Zhou, Xiaodong Li. Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases[J]. Front. Med., 2020, 14(6): 760-775.
[3] Qingwei Li, Han Wang, Xiuyang Li, Yujiao Zheng, Yu Wei, Pei Zhang, Qiyou Ding, Jiaran Lin, Shuang Tang, Yikun Zhao, Linhua Zhao, Xiaolin Tong. The role played by traditional Chinese medicine in preventing and treating COVID-19 in China[J]. Front. Med., 2020, 14(5): 681-688.
[4] Zhihang Peng, Wenyu Song, Zhongxing Ding, Quanquan Guan, Xu Yang, Qiaoqiao Xu, Xu Wang, Yankai Xia. Linking key intervention timings to rapid declining effective reproduction number to quantify lessons against COVID-19[J]. Front. Med., 2020, 14(5): 623-629.
[5] Mengxue Huang, Jingjing Wang, Runshun Zhang, Zhuying Ni, Xiaoying Liu, Wenwen Liu, Weilian Kong, Yao Chen, Tiantian Huang, Guihua Li, Dan Wei, Jianzhong Liu, Xuezhong Zhou. Symptom network topological features predict the effectiveness of herbal treatment for pediatric cough[J]. Front. Med., 2020, 14(3): 357-367.
[6] Qiqi Zhao, Xin Gao, Guangli Yan, Aihua Zhang, Hui Sun, Ying Han, Wenxiu Li, Liang Liu, Xijun Wang. Chinmedomics facilitated quality-marker discovery of Sijunzi decoction to treat spleen qi deficiency syndrome[J]. Front. Med., 2020, 14(3): 335-356.
[7] Ruijie Chang, Huwen Wang, Shuxian Zhang, Zezhou Wang, Yinqiao Dong, Lhakpa Tsamlag, Xiaoyue Yu, Chen Xu, Yuelin Yu, Rusi Long, Ning-Ning Liu, Qiao Chu, Ying Wang, Gang Xu, Tian Shen, Suping Wang, Xiaobei Deng, Jinyan Huang, Xinxin Zhang, Hui Wang, Yong Cai. Phase- and epidemic region-adjusted estimation of the number of coronavirus disease 2019 cases in China[J]. Front. Med., 2020, 14(2): 199-209.
[8] Li Ni, Ling Zhou, Min Zhou, Jianping Zhao, Dao Wen Wang. Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19[J]. Front. Med., 2020, 14(2): 210-214.
[9] Honglu Zhou, Songmei Wang, Lorenz von Seidlein, Xuanyi Wang. The epidemiology of norovirus gastroenteritis in China: disease burden and distribution of genotypes[J]. Front. Med., 2020, 14(1): 1-7.
[10] Yuan Gao, Zhilei Wang, Jinfa Tang, Xiaoyi Liu, Wei Shi, Nan Qin, Xiaoyan Wang, Yu Pang, Ruisheng Li, Yaming Zhang, Jiabo Wang, Ming Niu, Zhaofang Bai, Xiaohe Xiao. New incompatible pair of TCM: Epimedii Folium combined with Psoraleae Fructus induces idiosyncratic hepatotoxicity under immunological stress conditions[J]. Front. Med., 2020, 14(1): 68-80.
[11] Hudan Pan, Yanfang Zheng, Zhongqiu Liu, Zhongwen Yuan, Rutong Ren, Hua Zhou, Ying Xie, Liang Liu. Deciphering the pharmacological mechanism of Guan-Jie-Kang in treating rat adjuvant-induced arthritis using omics analysis[J]. Front. Med., 2019, 13(5): 564-574.
[12] Qing Pang, Hao Jin, Zhongran Man, Yong Wang, Song Yang, Zongkuang Li, Yimin Lu, Huichun Liu, Lei Zhou. Radical versus conservative surgical treatment of liver hydatid cysts: a meta-analysis[J]. Front. Med., 2018, 12(3): 350-359.
[13] Ting Liu, Faping Wang, Geng Wang, Hui Mao. Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled trials[J]. Front. Med., 2018, 12(3): 340-349.
[14] Fei Liu, Li Liu, Fang Zheng, Xiangdong Tang, Yongxin Bao, Yunxia Zuo. Identification of surgical patients at high risk of OSAS using the Berlin Questionnaire to detect potential high risk of adverse respiratory events in post anesthesia care unit[J]. Front. Med., 2018, 12(2): 189-195.
[15] Chongguang Yang, Qian Gao. Recent transmission of Mycobacterium tuberculosis in China: the implication of molecular epidemiology for tuberculosis control[J]. Front. Med., 2018, 12(1): 76-83.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed